# Failure to Warn: What the $851.6 Million Abbott Settlement Teaches Ohio Families About Hidden Risks ![A premature infant’s NICU incubator, specialty infant nutrition container, and medical chart representing hidden product risks and legal advocacy](https://cdn.marblism.com/Ngt946k5B-6.webp) *The reported Abbott settlement and Missouri verdict highlight an important question for Ohio families (what happens when a manufacturer knows, or should know, about a serious product risk but fails to provide an adequate warning?)* ## **A Major Settlement Puts Failure to Warn Claims in Focus** On August 20, 2026, Abbott announced agreements totaling approximately **$670 million** to resolve the *Gill* case and claims involving approximately 2,000 additional individuals relating to specialty formulas for preterm infants. The settlement follows a **$495 million Missouri jury verdict** in July 2024. The jury found in favor of an Illinois mother who alleged that Abbott’s preterm infant formula caused her daughter to develop necrotizing enterocolitis, or NEC, and that Abbott failed to warn about the alleged risk. Abbott stated that the settlement was a compromise of disputed claims and **not an admission of liability**. Abbott also continues to maintain that its products are safe and necessary for premature infants. The company reported that approximately 1,700 lawsuits remained pending after the agreements. The broader **$851.6 million figure** associated with the settlement and the Missouri *Gill* verdict reflects the extraordinary financial stakes surrounding the litigation. It does not represent one Ohio judgment, and it should not be treated as a simple mathematical addition of separate legal outcomes. The publicly announced settlement amount is approximately $670 million, while the Missouri verdict was a separate $495 million award. Still, the legal lesson is clear. **Warnings matter. Evidence matters. Accountability matters.** For Ohio families, the dispute provides a useful starting point for understanding **failure to warn** claims under the **Ohio Product Liability Act**. ## **Ohio’s Failure-to-Warn Standard Is Clear** Ohio Revised Code **2307.76** addresses when a product is defective because of an inadequate warning or instruction. Under [Ohio Revised Code 2307.76](https://codes.ohio.gov/ohio-revised-code/section-2307.76), a product may be defective due to an inadequate warning when: 1. The manufacturer **knew or, through reasonable care, should have known** about a risk associated with the product; and 2. The manufacturer failed to provide the warning or instruction that a reasonable manufacturer would have provided. The warning must be evaluated in light of two important factors: - The likelihood that the product would cause the type of harm claimed; and - The likely seriousness of that harm. This standard applies both when the product entered the market and, in appropriate circumstances, after the product was already being sold. A manufacturer may face a **post-marketing duty to warn** if it later learns of a significant risk and fails to provide a warning that a reasonable manufacturer would have provided. The law does not demand that every product carry a warning about every imaginable danger. It demands reasonable action when a manufacturer knows (or should know) about a risk that can cause serious harm. That is the heart of a failure-to-warn claim. ## **Hidden Risks Are Different From Obvious Risks** Ohio law also places limits on failure-to-warn claims. Under [R.C. 2307.76(B)](https://codes.ohio.gov/ohio-revised-code/section-2307.76), a product is not defective because of a failure to warn about a risk that is: - Open and obvious; or - A matter of common knowledge. For example, a manufacturer ordinarily does not need to warn that a sharp blade can cut or that a hot surface can burn. Those risks are apparent to ordinary users. But a risk may be hidden when it involves specialized medical products, complex ingredients, unusual interactions, or dangers that a reasonable consumer would not understand without accurate information. A family may reasonably rely on hospitals, physicians, and manufacturers when a product is used in a neonatal intensive care unit. Parents may not have the medical training or access to scientific data necessary to evaluate every potential danger. That reality makes the quality, timing, and audience of warnings especially important. **A hidden risk deserves a meaningful warning. A meaningful warning protects families.** ## **The Physician-Warning Rule for Ethical Drugs** Ohio’s warning law contains a special provision for **ethical drugs**, generally meaning prescription drugs. Under [R.C. 2307.76(C)](https://codes.ohio.gov/ohio-revised-code/section-2307.76), an ethical drug is not considered defective due to an inadequate warning when: - The manufacturer provides an otherwise adequate warning and instruction to the physician or legally authorized person who prescribes or dispenses the drug; and - The FDA has not required that the warning be given directly to the ultimate user. This provision reflects what is commonly called the **learned intermediary doctrine**. In many prescription-drug cases, the manufacturer’s duty runs to the prescribing physician rather than directly to the patient. That rule can create complicated legal questions. Did the manufacturer provide enough information to the physician? Did the physician receive the relevant risk information? Was the warning accurate, complete, and timely? Would a different warning have affected the medical decision? Not every medical product falls into the same legal category. Prescription drugs, medical devices, infant nutrition products, and consumer products may involve different rules and defenses. The product’s classification, method of distribution, intended user, and regulatory history all matter. An Ohio failure-to-warn case requires careful legal analysis (not assumptions). ![Attorney reviewing legal materials with a client, symbolizing professional guidance in a product liability case](https://cdn.marblism.com/PVMnOSVVFGF.webp) ## **What Evidence Matters in an Ohio Product Liability Case?** A strong failure-to-warn claim depends on evidence. Families should preserve information early because important records can disappear, become difficult to obtain, or get overlooked. Evidence may include: ### **The Product and Packaging** Keep the product, container, label, instructions, lot number, and expiration date whenever possible. Do not discard the remaining product unless a lawyer or qualified professional advises otherwise. Photographs can also help document: - The product’s appearance; - Warnings or missing warnings; - Instructions for use; - Packaging changes over time; and - Where and how the product was purchased or administered. ### **Medical and Treatment Records** Medical records can help establish: - The child’s condition before product use; - When the product was given; - The amount and duration of use; - Symptoms that developed; - Diagnoses and treatments; - Surgeries or hospitalizations; and - Long-term effects. Families should request complete records from hospitals, physicians, pharmacies, and other providers. A timeline can help connect the product’s use to the injury and identify possible alternative causes. ### **Warnings, Instructions, and Communications** Save instruction sheets, consent forms, discharge documents, emails, text messages, and written communications from medical providers or manufacturers. A case may turn on what a physician knew, what a family was told, and whether the warning actually reached the person making the relevant decision. ### **Scientific and Regulatory Information** Lawyers and experts may review: - Published medical studies; - Clinical research; - Adverse-event reports; - Regulatory communications; - Internal safety reviews; - Product testing; - Prior lawsuits or complaints; and - Changes to warnings or instructions. The key question is not simply whether a risk existed. The question is whether the manufacturer knew (or reasonably should have known) about the risk and failed to provide the warning that a reasonable manufacturer would have given. ### **Proof of Damages and Future Needs** Families may also need evidence of: - Medical expenses; - Rehabilitation; - Caregiving needs; - Lost income; - Emotional distress; - Disability; - Developmental complications; and - Future medical and support services. Injuries to a child can affect an entire family. Protecting the future requires more than documenting today’s bills. It requires understanding tomorrow’s needs. ![Organized medical records, product materials, and case notes being reviewed as evidence in a failure-to-warn claim](https://cdn.marblism.com/TCnGj0-M8hl.webp) ## **What Ohio Families Can Learn From the Abbott Litigation** The Abbott litigation does not automatically establish liability for every family, and a settlement or verdict in another state does not decide an Ohio claim. But it offers several important lessons. **First, familiar products can carry unfamiliar risks.** A product used in a hospital may appear trustworthy, necessary, and carefully regulated. Those facts do not eliminate the need for an adequate warning. **Second, the warning must reach the right decision-maker.** Ohio law may focus on communications to physicians for ethical drugs. The content and delivery of those communications can become central issues. **Third, preserving evidence is powerful.** Product records, medical records, timelines, and communications can help reveal what happened and what information was available. **Fourth, settlement headlines do not answer every legal question.** Each claim depends on its own facts, product, injury, medical history, warnings, and available evidence. **Fifth, families deserve a forceful advocate.** Manufacturers and large institutions often have substantial resources. Injured families should not have to investigate complex product risks alone. ## **How Braden Blumenstiel Legal Advocates Group Helps** At [Braden Blumenstiel Legal Advocates Group, LLC](https://www.bblag.com/), we represent individuals and families who have been injured and need strong, strategic legal advocacy. Our [defective products and medical devices practice](https://www.bblag.com/defective-products-and-medical-devices) focuses on investigating whether a product was unsafe, whether a manufacturer provided an adequate warning, and whether a hidden risk caused preventable harm. We work to: - Preserve critical evidence; - Investigate the product’s history; - Review medical and regulatory records; - Identify responsible parties; - Consult qualified experts; - Calculate present and future damages; and - Pursue accountability through negotiation or litigation. We believe legal representation should do more than react to harm. It should correct wrongdoing and protect what comes next. **Righting Wrongs. Protecting Futures.** That is our promise. That is our purpose. That is the work. ## **The Takeaway (A Warning Can Change a Life)** The Abbott settlement and Missouri *Gill* verdict place failure-to-warn claims in the national spotlight. For Ohio families, the central issue under the Ohio Product Liability Act is whether a manufacturer knew or should have known about a harmful risk and failed to provide the warning a reasonable manufacturer would have given. Hidden risks demand careful investigation. Serious injuries demand decisive action. Families deserve answers, accountability, and protection for the future. If your child or family member suffered harm after using a product, **preserve the product and records, write down what happened, and seek legal guidance promptly**. Do not let a hidden risk become a hidden injustice. **Drop us a line.** Call Braden Blumenstiel Legal Advocates Group at **614-508-1677** or **888-343-9796**. **Righting Wrongs. Protecting Futures.**